Dr Ami Glicksman, the co-founder of UltraShape™ and an Israeli board certified plastic surgeon, is stepping down from his position as the company’s president.

Dr Glicksman, who has held the role since the company’s inception in 2000, decided to decrease his involvement in the company for personal reasons.
Dr Glicksman will continue to serve as a consultant for the company and will remain on UltraShape’s board of directors. 

Commenting on the change in role, Dr Glicksman said, “I am very happy to remain involved in the company’s activities, focusing on what I do best - drawing on my entrepreneurial skills and extensive experience in the field of medicine and particularly plastic surgery. I look forward to this new challenge not just as an individual but as part of an organization within a growing global market. We envisage a very successful year ahead for UltraShape.” 

UltraShape, an Israeli company specialising in non-invasive body contouring, was founded in 2000 by Dr Glicksman and Dr Yoram Eshel, the company’s CEO. Both head up an expert team of scientists dedicated to the development of cutting-edge body-contouring technology in a bid to enhance patients’ self-image and sense of well-being. Dr. Glicksman was instrumental in developing UltraShape’s Contour I, which received the CE Mark within 5 years of inception. UltraShape is the first and only commercial system available on the market for non-invasive body contouring that uses unique G-NIUS™ (Guided Non-Invasive Focused Ultrasound Selective) technology to effectively and safely break down fat cells. 

Commenting on the announcement, co-founder and CEO Yoram Eshel said, “UltraShape has expanded significantly in the past year, with distribution in 35 countries worldwide, installation of 150 UltraShape systems and 14,000 treatments administered to date. We see a promising future for this rapidly growing company, and look forward to benefiting from Dr Glicksman’s expertise and continuing strategic direction as active board member and consultant.” 

About UltraShape

UltraShape is redefining aesthetic medicine by developing, manufacturing, and marketing innovative non-invasive devices for body contouring. The Company is dedicated to providing healthcare professionals with leading edge solutions that enhance the lives of patients worldwide. The UltraShape proprietary technology is based on focused ultrasound waves that selectively disrupt adipose (fat) cells without affecting surrounding tissues. The safety and effectiveness of the UltraShape surgery-free solution has been clinically proven in hundreds of patients. The Company’s products are marketed in over 35 countries. UltraShape Ltd. is a privately held company founded in 2000. For more information visit www.ultrashape.com.